Vimarsana
Biggest News Aggregation in the World

Page 22 - Quest Partners News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Quest Partners. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Quest Partners Today - Breaking & Trending Today

Premier Fund Managers Ltd Sells 3,310 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX) - Vimarsana News

Premier Fund Managers Ltd Sells 3,310 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)

Premier Fund Managers Ltd cut its holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 2.6% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 124,533 shares of the company’s stock after selling 3,310 shares during the period. Premier Fund […]

Rhenman & Partners Asset Management AB Has $4.18 Million Holdings in Revance Therapeutics, Inc. (NASDAQ:RVNC) - Vimarsana News

Rhenman & Partners Asset Management AB Has $4.18 Million Holdings in Revance Therapeutics, Inc. (NASDAQ:RVNC)

Rhenman & Partners Asset Management AB boosted its stake in Revance Therapeutics, Inc. (NASDAQ:RVNC – Free Report) by 31.6% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 475,872 shares of the biopharmaceutical company’s stock after purchasing an additional 114,193 shares during the quarter. Rhenman […]

Exact Sciences Co. (NASDAQ:EXAS) Shares Bought by Rhenman & Partners Asset Management AB - Vimarsana News

Exact Sciences Co. (NASDAQ:EXAS) Shares Bought by Rhenman & Partners Asset Management AB

Rhenman & Partners Asset Management AB boosted its position in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 3.1% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 165,000 shares of the medical research company’s stock after acquiring an additional 5,000 shares during […]

Rhenman & Partners Asset Management AB Has $4.18 Million Holdings in Revance Therapeutics, Inc. (NASDAQ:RVNC) - Vimarsana News

Rhenman & Partners Asset Management AB Has $4.18 Million Holdings in Revance Therapeutics, Inc. (NASDAQ:RVNC)

Rhenman & Partners Asset Management AB boosted its stake in Revance Therapeutics, Inc. (NASDAQ:RVNC – Free Report) by 31.6% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 475,872 shares of the biopharmaceutical company’s stock after purchasing an additional 114,193 shares during the quarter. Rhenman […]

Rhenman & Partners Asset Management AB Sells 217,894 Shares of Pliant Therapeutics, Inc. (NASDAQ:PLRX) - Vimarsana News

Rhenman & Partners Asset Management AB Sells 217,894 Shares of Pliant Therapeutics, Inc. (NASDAQ:PLRX)

Rhenman & Partners Asset Management AB cut its holdings in Pliant Therapeutics, Inc. (NASDAQ:PLRX – Free Report) by 65.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 112,741 shares of the company’s stock after selling 217,894 shares during the period. Rhenman […]

Source: wkrb13.com